NFKB1 and periodontitis: LincRNA‐EPS inhibits the LPS‐induced production and activation of caspase‐11 and NLRP3 inflammasomes by suppressing the activation of the NF‐κB signalling pathway via interacting with TDP43, thereby alleviating periodontitis.